Indeed, the melanoma cells used in this study likely express lower levels of AR and SLNCR than EGR1, likely explaining why knockdown of EGR1 decreases p21 (Table S1; Figures 6A-6D; Schmidt et al., 2016). The gene discussed is EGR1; the disease is melanoma.